Advertising for Profit
When a drug manufacturer produces a drug, it must be tested to determine its potential uses as well as side-effects. After several levels of experimentation, manufacturers submit their reports to the US Food and Drug Administration (FDA) for approval. If approved, the drug will enter the market for its intended uses, with its known side-effects listed. Unfortunately, sometimes a drug that is unsafe for public use or improperly marketed is released. When this happens, innocent patients may suffer the consequences.
If you have suffered adverse and unexpected side effects while taking a drospirenone-containing oral contraceptive, such as YAZ, Yasmin, or Ocella, you may be eligible to receive compensation for your losses. Contact the YAZ side-effect attorneys of Williams Kherkher today to discuss your grounds for filing a claim. Call 800-761-3187 to schedule a free initial consultation.
Marketing Yaz, Yasmin, and Ocella
Initially, Bayer improperly marketed YAZ, Yasmin, and Ocella as treatment for all forms of acne and premenstrual syndrome (PMS). Between the years of 2001 and 2008, Bayer’s marketing had resulted in significant revenue:
- YAZ –Sales of $616 million
- Yasmin-Sales of $382 million
- Ocella-Sales of$170 million
In October 2008, the FDA was so concerned with the improper advertising of these medications that it issued a warning letter to Bayer to cease promotion of Yasmin and YAZ. In response, Bayer ran a corrective campaign which only promoted YAZ, Yasmin and Ocella as treatment for premenstrual dysphoric disorder (PMDD), a severe form of PMS, and moderate acne vulgaris.
If you or someone you know has been a victim of a drospirenone-containing oral contraceptive, such as YAZ, Yasmin, or Ocella, contact the YAZ side-effect attorneys of Williams Kherkher to learn about your legal options. Call 800-761-3187 today to schedule a free case evaluation.